Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 18, 2024Arthritis & Rheumatology

Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long‐Term Normalization of Systemic Sclerosis Molecular Signatures

View Full Paper
Ask AI
Bookmark
Share

Authors

NWNancy WareingXWXuan WangLKLynette Keyes‐Elstein

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wareing et al. (2024) studied this question.

synapsesocial.com/papers/68e7388db6db6435876b1c1dhttps://doi.org/10.1002/art.42847
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Scleroderma (systemic sclerosis): classification, subsets and pathogenesis2001 · 3,972 citations
  2. 2Cyclophosphamide versus Placebo in Scleroderma Lung Disease2006 · 1,684 citations
  3. 3Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations2013 · 318 citations
  4. 4Preliminary criteria for the classification of systemic sclerosis (scleroderma)1980 · 4,951 citations
  5. 5Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis2022 · 16 citations